Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae: An observational study
High-dose intravenous fosfomycin can be considered for treatment of hospitalized patients with KPC-Kp UTI in some scenarios. in vitro fosfomycin susceptibility testing for multiresistant KPC-Kp may be of limited clinical value.
Authors
- M. Rosa
- Ángela Cano (ORCID: https://orcid.org/0000-0002-7801-9778)
- Jorge Rodríguez-Gómez
- Julia Guzmán-Puche (ORCID: https://orcid.org/0000-0003-2199-7949)
- C. De La Fuente-Martos
- Irene Gracia-Ahufinger (ORCID: https://orcid.org/0000-0001-7714-6620)
- Cristina Vázquez (ORCID: https://orcid.org/0000-0001-6333-7960)
- Julián Torre‐Cisneros (ORCID: https://orcid.org/0000-0003-1529-6302)
- Alejandra M. Natera
- Rafael Camino León
- Juan José Castón
- Elena Pérez‐Nadales (ORCID: https://orcid.org/0000-0002-6796-1813)
- Luis Martínez-Martínez
- Juan Jesús Pineda-Capitán
- Rosario Carmona-Flores
Institutions
- Instituto de Salud Carlos III (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Hospital Universitario Reina Sofía (ES)
- University of Córdoba (ES)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1016/j.jgar.2024.12.013
- Citations
- 1
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.39